IDH1 and central nervous system cancer: IDH1 mutation has been observed as an early evidence and in high frequency (50%-93%) among astrocytomas, oligodendrogliomas, oligodendro-gliomas and secondary glioblastomas, while rarely occurs in primary glioblastoma [2-6,11,12].